Journal of drugs in dermatology : JDD 2010-09-01

Urticarial hypersensitivity reaction caused by temozolomide.

Salma Pothiawala, Mei-Yu Hsu, Clarissa Yang, Santosh Kesari, Omar A Ibrahimi

文献索引：Journal. of. Drugs in. Dermatology. 9(9) , 1142-4, (2010)

全文：HTML全文

摘要

Temozolomide is an oral alkylating agent approved for the treatment of glioblastoma and anaplastic astrocytoma, and is currently under clinical investigation for the treatment of brain metastases from a variety of cancers. Temozolomide is well tolerated, and the reported dermatologic side effects of this medication are limited. Here, the authors report the first case of an urticarial hypersensitivity reaction induced by temozolomide. As this drug will likely be increasingly utilized in the near future, it is important to be aware of its potential to cause adverse cutaneous manifestations.

相关化合物

  • 醋酸氟轻松

相关文献：

Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis.

2011-02-01

[Journal. of. Drugs in. Dermatology. 10(2) , 171-6, (2011)]

In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.

2008-01-01

[Journal. of. Drugs in. Dermatology. 7(1) , 28-32, (2008)]

The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.

2009-08-01

[Journal. of. Drugs in. Dermatology. 8(8) , 751-5, (2009)]

Reticulated phototoxic eruption in a patient on long-term diltiazem therapy.

2008-08-01

[Journal. of. Drugs in. Dermatology. 7(8) , 792-3, (2008)]

Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.

2010-10-01

[Cutis. 86(4) , 208-13, (2010)]

更多文献...